37 related articles for article (PubMed ID: 16682957)
1. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.
Benoit V; de Moraes E; Dar NA; Taranchon E; Bours V; Hautefeuille A; Tanière P; Chariot A; Scoazec JY; de Moura Gallo CV; Merville MP; Hainaut P
Oncogene; 2006 Sep; 25(42):5708-18. PubMed ID: 16682957
[TBL] [Abstract][Full Text] [Related]
2. Caspase-3 knockout attenuates radiation-induced tumor repopulation via impairing the ATM/p53/Cox-2/PGE
Zhao M; Wang Y; Zhao Y; He S; Zhao R; Song Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Huang Q
Aging (Albany NY); 2020 Nov; 12(21):21758-21776. PubMed ID: 33180744
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.
Hidalgo-Estévez AM; Stamatakis K; Jiménez-Martínez M; López-Pérez R; Fresno M
Front Pharmacol; 2020; 11():533. PubMed ID: 32410997
[TBL] [Abstract][Full Text] [Related]
4. Is p53 Involved in Tissue-Specific Insulin Resistance Formation?
Strycharz J; Drzewoski J; Szemraj J; Sliwinska A
Oxid Med Cell Longev; 2017; 2017():9270549. PubMed ID: 28194257
[TBL] [Abstract][Full Text] [Related]
5. The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.
Moris D; Kontos M; Spartalis E; Fentiman IS
Breast Care (Basel); 2016 Oct; 11(5):339-344. PubMed ID: 27920627
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis.
Rigby CM; Roy S; Deep G; Guillermo-Lagae R; Jain AK; Dhar D; Orlicky DJ; Agarwal C; Agarwal R
Carcinogenesis; 2017 Jan; 38(1):40-50. PubMed ID: 27729375
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer.
Chen J; Wu F; Pei HL; Gu WD; Ning ZH; Shao YJ; Huang J
Oncol Lett; 2015 Oct; 10(4):2197-2203. PubMed ID: 26622818
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.
Haque S; Yan XJ; Rosen L; McCormick S; Chiorazzi N; Mongini PK
FASEB J; 2014 Feb; 28(2):627-43. PubMed ID: 24145719
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression.
Ortega FJ; Moreno-Navarrete JM; Mayas D; Serino M; Rodriguez-Hermosa JI; Ricart W; Luche E; Burcelin R; Tinahones FJ; Frühbeck G; Mingrone G; Fernández-Real JM
Int J Obes (Lond); 2014 May; 38(5):737-45. PubMed ID: 23999197
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.
Clemons NJ; Phillips WA; Lord RV
Cancer Biol Ther; 2013 Sep; 14(9):782-95. PubMed ID: 23792587
[TBL] [Abstract][Full Text] [Related]
11. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.
Falk GW; Buttar NS; Foster NR; Ziegler KL; Demars CJ; Romero Y; Marcon NE; Schnell T; Corley DA; Sharma P; Cruz-Correa MR; Hur C; Fleischer DE; Chak A; Devault KR; Weinberg DS; Della'Zanna G; Richmond E; Smyrk TC; Mandrekar SJ; Limburg PJ;
Gastroenterology; 2012 Oct; 143(4):917-26.e1. PubMed ID: 22796132
[TBL] [Abstract][Full Text] [Related]
12. Expression of COX2 and p53 in Rat Esophageal Cancer Induced by Reflux of Duodenal Contents.
Hashimoto N
ISRN Gastroenterol; 2012; 2012():914824. PubMed ID: 22272378
[TBL] [Abstract][Full Text] [Related]
13. Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.
Barakat K; Issack BB; Stepanova M; Tuszynski J
PLoS One; 2011; 6(11):e27651. PubMed ID: 22110706
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
Brasky TM; Bonner MR; Moysich KB; Ambrosone CB; Nie J; Tao MH; Edge SB; Kallakury BV; Marian C; Goerlitz DS; Trevisan M; Shields PG; Freudenheim JL
Cancer Causes Control; 2011 Jul; 22(7):965-75. PubMed ID: 21516318
[TBL] [Abstract][Full Text] [Related]
15. FAK and p53 protein interactions.
Golubovskaya VM; Cance WG
Anticancer Agents Med Chem; 2011 Sep; 11(7):617-9. PubMed ID: 21355845
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase and p53 signal transduction pathways in cancer.
Golubovskaya VM; Cance W
Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
[TBL] [Abstract][Full Text] [Related]
17. Regulation of MCP-1 chemokine transcription by p53.
Hacke K; Rincon-Orozco B; Buchwalter G; Siehler SY; Wasylyk B; Wiesmüller L; Rösl F
Mol Cancer; 2010 Apr; 9():82. PubMed ID: 20406462
[TBL] [Abstract][Full Text] [Related]
18. A crucial role for adipose tissue p53 in the regulation of insulin resistance.
Minamino T; Orimo M; Shimizu I; Kunieda T; Yokoyama M; Ito T; Nojima A; Nabetani A; Oike Y; Matsubara H; Ishikawa F; Komuro I
Nat Med; 2009 Sep; 15(9):1082-7. PubMed ID: 19718037
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.
Ogino S; Kirkner GJ; Nosho K; Irahara N; Kure S; Shima K; Hazra A; Chan AT; Dehari R; Giovannucci EL; Fuchs CS
Clin Cancer Res; 2008 Dec; 14(24):8221-7. PubMed ID: 19088039
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Dietary PPARgamma Ligands for Metastasis in Colorectal Cancer.
Kuniyasu H
PPAR Res; 2008; 2008():529720. PubMed ID: 18551182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
